Westler Lifescience India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 292.71%
(FY 2020)
- Profit 110.43%
(FY 2020)
- Ebitda 98.45%
(FY 2020)
- Net Worth 26.43%
(FY 2020)
- Total Assets 17.30%
(FY 2020)
About Westler Lifescience India
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Stelinpullamkottu Mathai and Jobi Cherian serve as directors at the Company.
- CIN/LLPIN
U24100KL2018PTC055590
- Company No.
055590
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2018
- Date of AGM
05 Oct 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Westler Lifescience India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jobi Cherian  | Managing Director | 21-Nov-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Stelinpullamkottu Mathai | Director | 21-Nov-2018 | Current |
Financial Performance of Westler Lifescience India.
Westler Lifescience India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 292.71% increase. The company also saw a substantial improvement in profitability, with a 110.43% increase in profit. The company's net worth Soared by an impressive increase of 26.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Westler Lifescience India?
Unlock access to Westler Lifescience India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Biocent Scientific India Private LimitedActive 8 years 1 monthStelinpullamkottu Mathai is a mutual person
Renauxe Pharma India Private LimitedActive 14 years 8 monthsStelinpullamkottu Mathai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Westler Lifescience India?
Unlock and access historical data on people associated with Westler Lifescience India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Westler Lifescience India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Westler Lifescience India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
